Previous Article | Next Article 
Journal of Virology, April 1999, p. 3491-3496, Vol. 73, No. 4
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Ebola Virus Selectively Inhibits Responses to
Interferons, but Not to Interleukin-1
, in Endothelial
Cells
Brian H.
Harcourt,1
Anthony
Sanchez,2 and
Margaret K.
Offermann1,3,*
Program in Genetics and Molecular
Biology1 and Winship Cancer Center and
Division of Hematology and Oncology, Department of Internal
Medicine,3 Emory University, Atlanta, Georgia
30322, and Special Pathogens Branch, Division of Viral and
Rickettsial Diseases, National Center for Infectious Diseases, Centers
for Disease Control and Prevention, Atlanta, Georgia
303332
Received 9 October 1998/Accepted 21 December 1998
Ebola virus infection is highly lethal and leads to severe
immunosuppression. In this study, we demonstrate that infection of
human umbilical vein endothelial cells (HUVECs) with Ebola virus Zaire
(EZ) suppressed basal expression of the major histocompatibility complex class I (MHC I) family of proteins and inhibited the induction of multiple genes by alpha interferon (IFN-
) and IFN-
, including those coding for MHC I proteins, 2'-5' oligoadenylate synthetase [2'-5'(A)N], and IFN regulatory factor 1 (IRF-1).
Induction of interleukin-6 (IL-6) and ICAM-1 by IL-1
was not
suppressed by infection with EZ, suggesting that the inhibition of IFN
signaling is specific. Gel shift analysis demonstrated that infection
with EZ blocked the induction by IFNs of nuclear proteins that bind to
IFN-stimulated response elements, gamma activation sequences, and IFN
regulatory factor binding site (IRF-E). In contrast, infection with EZ
did not block activation of the transcription factor NF-
B by
IL-1
. The events that lead to the blockage of IFN signaling may be
critical for Ebola virus-induced immunosuppression and would play a
role in the pathogenesis of Ebola virus infection.
*
Corresponding author. Mailing address: Winship Cancer
Center, 1365 B Clifton Rd., Atlanta, GA 30322. Phone: (404) 778-5808. Fax: (404) 778-5016. E-mail: mofferm{at}emory.edu.
Journal of Virology, April 1999, p. 3491-3496, Vol. 73, No. 4
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Chahine, M. N., Pierce, G. N.
(2009). Therapeutic Targeting of Nuclear Protein Import in Pathological Cell Conditions. Pharmacol. Rev.
61: 358-372
[Abstract]
[Full Text]
-
Prins, K. C., Cardenas, W. B., Basler, C. F.
(2009). Ebola Virus Protein VP35 Impairs the Function of Interferon Regulatory Factor-Activating Kinases IKK{varepsilon} and TBK-1. J. Virol.
83: 3069-3077
[Abstract]
[Full Text]
-
Reid, St. P., Valmas, C., Martinez, O., Sanchez, F. M., Basler, C. F.
(2007). Ebola Virus VP24 Proteins Inhibit the Interaction of NPI-1 Subfamily Karyopherin {alpha} Proteins with Activated STAT1. J. Virol.
81: 13469-13477
[Abstract]
[Full Text]
-
Feng, Z., Cerveny, M., Yan, Z., He, B.
(2007). The VP35 Protein of Ebola Virus Inhibits the Antiviral Effect Mediated by Double-Stranded RNA-Dependent Protein Kinase PKR. J. Virol.
81: 182-192
[Abstract]
[Full Text]
-
Reid, St. P., Leung, L. W., Hartman, A. L., Martinez, O., Shaw, M. L., Carbonnelle, C., Volchkov, V. E., Nichol, S. T., Basler, C. F.
(2006). Ebola Virus VP24 Binds Karyopherin {alpha}1 and Blocks STAT1 Nuclear Accumulation.. J. Virol.
80: 5156-5167
[Abstract]
[Full Text]
-
Alazard-Dany, N., Volchkova, V., Reynard, O., Carbonnelle, C., Dolnik, O., Ottmann, M., Khromykh, A., Volchkov, V. E.
(2006). Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level.. J. Gen. Virol.
87: 1247-1257
[Abstract]
[Full Text]
-
Kash, J. C., Muhlberger, E., Carter, V., Grosch, M., Perwitasari, O., Proll, S. C., Thomas, M. J., Weber, F., Klenk, H.-D., Katze, M. G.
(2006). Global Suppression of the Host Antiviral Response by Ebola- and Marburgviruses: Increased Antagonism of the Type I Interferon Response Is Associated with Enhanced Virulence. J. Virol.
80: 3009-3020
[Abstract]
[Full Text]
-
Huber, J. D., Campos, C. R., Mark, K. S., Davis, T. P.
(2006). Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after {lambda}-carrageenan-induced inflammatory pain. Am. J. Physiol. Heart Circ. Physiol.
290: H732-H740
[Abstract]
[Full Text]
-
Sanchez, A., Lukwiya, M., Bausch, D., Mahanty, S., Sanchez, A. J., Wagoner, K. D., Rollin, P. E.
(2004). Analysis of Human Peripheral Blood Samples from Fatal and Nonfatal Cases of Ebola (Sudan) Hemorrhagic Fever: Cellular Responses, Virus Load, and Nitric Oxide Levels. J. Virol.
78: 10370-10377
[Abstract]
[Full Text]
-
Lin, R.-J., Liao, C.-L., Lin, E., Lin, Y.-L.
(2004). Blocking of the Alpha Interferon-Induced Jak-Stat Signaling Pathway by Japanese Encephalitis Virus Infection. J. Virol.
78: 9285-9294
[Abstract]
[Full Text]
-
Kaiser, W. J., Kaufman, J. L., Offermann, M. K.
(2004). IFN-{alpha} Sensitizes Human Umbilical Vein Endothelial Cells to Apoptosis Induced by Double-Stranded RNA. J. Immunol.
172: 1699-1710
[Abstract]
[Full Text]
-
Basler, C. F., Mikulasova, A., Martinez-Sobrido, L., Paragas, J., Muhlberger, E., Bray, M., Klenk, H.-D., Palese, P., Garcia-Sastre, A.
(2003). The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3. J. Virol.
77: 7945-7956
[Abstract]
[Full Text]
-
Simmons, G., Wool-Lewis, R. J., Baribaud, F., Netter, R. C., Bates, P.
(2002). Ebola Virus Glycoproteins Induce Global Surface Protein Down-Modulation and Loss of Cell Adherence. J. Virol.
76: 2518-2528
[Abstract]
[Full Text]
-
Sundstrom, J. B., McMullan, L. K., Spiropoulou, C. F., Hooper, W. C., Ansari, A. A., Peters, C. J., Rollin, P. E.
(2001). Hantavirus Infection Induces the Expression of RANTES and IP-10 without Causing Increased Permeability in Human Lung Microvascular Endothelial Cells. J. Virol.
75: 6070-6085
[Abstract]
[Full Text]
-
Bray, M.
(2001). The role of the Type I interferon response in the resistance of mice to filovirus infection. J. Gen. Virol.
82: 1365-1373
[Abstract]
[Full Text]
-
Basler, C. F., Wang, X., Mühlberger, E., Volchkov, V., Paragas, J., Klenk, H.-D., García-Sastre, A., Palese, P.
(2000). The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc. Natl. Acad. Sci. USA
10.1073/pnas.220398297v1
[Abstract]
[Full Text]
-
Basler, C. F., Wang, X., Muhlberger, E., Volchkov, V., Paragas, J., Klenk, H.-D., Garcia-Sastre, A., Palese, P.
(2000). The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc. Natl. Acad. Sci. USA
97: 12289-12294
[Abstract]
[Full Text]